期刊文献+

儿童社区获得性肺炎的致病菌分布及耐药性分析 被引量:9

Pathogen distribution and drug resistance of community-acquired pneumonia in children
原文传递
导出
摘要 目的探讨我院儿童社区获得性肺炎(CAP)细菌感染情况及药敏情况,为抗生素的合理使用提供依据。方法以本院2010年1月至2013年12月儿科收治的CAP患儿为研究对象,回顾性分析CAP的病原菌分布和耐药情况。菌株鉴定使用法国梅里埃VITEK32分析仪,用纸片扩散法做药敏试验。结果病原菌以革兰阴性菌为主,前四位分别为肺炎克雷伯杆菌、大肠埃希菌、流感嗜血杆菌和阴沟肠杆菌;革兰阳性菌次之,主要为肺炎链球菌和金黄色葡萄球菌。药敏结果显示,主要革兰阴性菌对头孢吡肟、哌拉西林/他唑巴坦、头孢哌酮/舒巴坦和亚胺培南耐药率较低;主要革兰阳性菌对左氧氟沙星、莫昔沙星和万古霉素耐药率较低。结论了解CAP患儿病原菌分布,有利于在儿童CAP经验性治疗时制定正确的治疗方案。 Objective To explore the distribution and drug susceptibility of the pathogens in pediatric communityacquired pneumonia( CAP) cases in our hospital and provide basis for rational use of antibiotics. Methods Retrospective analysis was performed to analyze the pathogen distribution and drug resistance in CAP patients admitted in our hospital from Jan. 2010 to Dec. 2013. The identification was done by Bio-Merieux VITEK32; antimicrobial susceptibility test was performed with K-B method. Results Gram-negative bacteria was the predominant pathogenic bacteria; the top four were Klebsiella pneumoniae,Escherichia coli,Haemophilus influenzae and Enterobacter cloacae. Gram-positive bacteria was the second,mainly Streptococcus pneumoniae and Staphylococcus aureus. The resistance rates of main Gram-negative bacteria to Cefepime,Piperacillin / tazobactam,Cefoperazone / sulbactam and Imipenem were lower,while the resistance rates of main Gram-positive bacteria to Levofloxacin,Moxifloxacin and Vancomycin were lower. Conclusion This result would be helpful to choose proper empirical treatment option for pediatric CAP.
出处 《中国微生态学杂志》 CAS CSCD 2015年第5期581-583,共3页 Chinese Journal of Microecology
关键词 儿童 社区获得性肺炎 病原菌 分布 耐药性 Community-acquired pneumonia Pathogenic bacteria Distribution Drug resistance
  • 相关文献

参考文献9

  • 1陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:607
  • 2Clinical and Laboratory Standards Institute/NCCLS. Performance standards for antimicrobial susceptibility testing, Fifteenth informa- tional supplement CLSI documentM100-S15[ S]. Clinical and Labo- ratory Standards Institute Wayne Pennsylvania, 2005, 25 ( 1 ) : 1- 106.
  • 3Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemialogy and eti- ology of childhood pneumonia[J]. Bull World Health Organ, 2008, 86(5) : 408-416.
  • 4Thiem U, Heppner HJ, Pientka L. Elderly patients with communi- ty-acquired pneumonia: optimal treatment strategies[ J]. Drugs Ag- ing, 2011, 28(7): 519-537.
  • 5刘俊英.儿童社区获得性肺炎病原体及细菌药敏结果分析[J].中国病原生物学杂志,2012,7(11):855-857. 被引量:6
  • 6焦明远,聂庆东,伊洁.儿童社区获得性肺炎的病原体研究[J].中华医院感染学杂志,2013,23(14):3550-3551. 被引量:25
  • 7Falade AG, Ayede AI. Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing coun- tries-a review[J]. Afr J Med Sci, 2011, 40(4) : 293-308.
  • 8Sridhar RN, Basavarappa KG, Krishna GL. Detection of extended spectrum beta -lactamase from clinical isolates in Davangere [ J ]. In- dian J Pathol Microbiol 2008, 51 (4) : 497-499.
  • 9李高莲,周义正.重症监护病房下呼吸道感染病原菌的分布及耐药性分析[J].中国微生态学杂志,2013,25(2):195-197. 被引量:7

二级参考文献26

共引文献639

同被引文献85

  • 1袁壮,马沛然,邓力,方鹤松,卢競,江载芳,陈贤楠,陆权,张乾忠,张灵恩,范永琛,洪建国,胡仪吉,胡皓夫,赵祥文,赵顺英,耿荣,夏经,曹玲,鲁继荣,傅文永.50年来小儿肺炎诊治策略的变迁[J].中国实用儿科杂志,2006,21(12):881-908. 被引量:160
  • 2Pneumococcal vaccines WHO position paper-2012 [J]. Wkly Epidemiol Rec, 2012,87(14) : 129-144.
  • 3Pellegrino P,Carnovale C,Perrone V,et al. Epidemiological analysis on two decades of hospitalisations for meningitis in the United States [J]. Eur J Clin Microbi01 Infect Dis, 2014,33(9) : 1519-1524.
  • 4Van der Veen EL,Schilder AG,Timmers TK,et al. Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized, double-blind, placebo-controlled trial in children [J]. J Antimicrob Chemother, 2009,63 (5) : 1011 - 1016.
  • 5Kirchner M, Mafura M, Hunt T,et al. Antimicrobial resis- tance characteristics and fitness of Gram-negative fecal bacteria from volunteers treated with minocycline or amox- icillin [J]. Front Microbiol,2014,5(722) : 1-9.
  • 6Lauw FN, Branger J, Florquin S, et al. IL- 18 improvesthe early antimicrobial host response to pneumococcal pneu- monia [J]. J Immunol, 2002,168 (1) : 372-378.
  • 7Golden AR, Rosenthal M, Fultz B, et al. Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13 [J]. J Antimicrob Chemother,2015,70(8):2199- 2202.
  • 8Chauvin C,Le Devendec L,Jouy E,et al. National preva- lence of resistance to third-generation cephalosporins in Escherichia coli isolates from layer flocks in France [J]. Antimicrob Agents Chemother, 2013,57 (12) : 6351-6353.
  • 9Zilberberg MD, Shorr AF. Prevalence of muhidrug-resis- rant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009 [J]. J Hosp Med, 2013,8 (10) : 559-563.
  • 10Li D, Kirsop J,Tang WH. Listening to our gut:contribu- tion of gut microbiota and cardiovascular risk in diabetes pathogenesis [J]. Curr Diab Rep, 2015,15 (9) : 634.

引证文献9

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部